Antibe Therapeutics Inc(Pre-Merger) T.ATE

Alternate Symbol(s): ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

TSX:ATE - Post by User

Antibe Therapeutics Inc(Pre-Merger) > Never Boring

<< Previous

Bullboard Posts

Next >>

Comment by Hideawayon Oct 22, 2020 9:54am

196 Views

Post# 31761322

RE:RE:RE:RE:RE:RE:RE:Never Boring

Pragmatist,liked your response.You mention that you don't foresee any adverse events during next six months.However, there seems to be some concern if Biden wins and Trump does not accept the results.Some commentary suggest dire consequences of such action.
I feel there will be some disruption and civil unrest but hopefully not prolonged and severe.
It would have an adverse affect on the markets depending on the length and intensity of disruptions.
I,personally, am concerned for all my holdings and at times feel I like I should unload some of my positions.
Comments appreciated.

<< Previous

Bullboard Posts

Next >>

Advancing an underexplored area of the Yukon with the same geology as B.C’.s Golden Triangle